[November 27, 2015]

Research and Markets: 2015 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges

Research and Markets (http://www.researchandmarkets.com/research/nmh9j7/2015_hematology) has announced the addition of the "2015 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market" report to their offering.

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide.

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-toubleshooting, autocalibration and other advanced features.

Scope of the Report:

Geographic Coverage:

• France
• Germany
• Italy
• Japan
• Spain
• UK
• USA

Strategic Recommendations:

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
  

Current and Emerging Products:

• Analysis of current and emerging hematology and flow cytometry assays.
• Reagent and instrument sales forecasts by market segment.
• Instrument placements and installed base by manufacturer and model.
• Sales and market shares of reagent and instrument suppliers.
  

Instrumentation Review:

• The study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
  

Technology Review:

• Assessment of current and emerging technologies and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and products by test.
  

Competitive Assessments

• Extensive strategic profiles of major suppliers and emerging market entrants.
  

Companies mentioned:

• Abbott
• Agilent Technologies
• Beckman Coulter/Danaher (News - Alert)
• Becton Dickinson
• Bio-Rad
• CellaVision
• Horiba
• Iris/Danaher
• Nihon Kohden
• Ortho-Clinical Diagnostics
• Roche
• Siemens (News - Alert)
• Sysmex
  

For more information visit http://www.researchandmarkets.com/research/nmh9j7/2015_hematology

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005157/en/

[ Back To TMCnet.com's Homepage ]